Neurocrine Biosciences to Present at the Bank of America Securities 2020 Napa Biopharma Conference
Retrieved on:
Monday, June 15, 2020
SAN DIEGO, June 15, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Securities 2020 Napa Biopharma Conference at 2:00 p.m. PT (5:00 p.m.
Key Points:
- SAN DIEGO, June 15, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Securities 2020 Napa Biopharma Conference at 2:00 p.m. PT (5:00 p.m.
- ET) on Monday, June 22, 2020.
- Kevin Gorman, Chief Executive Officer, will present at the conference.
- Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.